Skip to main content

UK allocations of funding for vaccines and tests aganist the coronavirus examined

15 June 2020

The International Development Committee takes evidence from development stakeholders.


Tuesday 16 June 2020 (virtual)

  • Please note there is no physical access to Parliament
  • Session will be conducted with remote participation by witnesses and Committee members

Discussion with first panel POSTPONED due to urgent business in the House

  • Dr Josie Golding, Epidemics Lead, Wellcome Trust (CEPI & CTA)
  • Dr John Nkengasong, Director, Africa CDC (also CEPI)
  • Samia Saad, Director of Resource Mobilisation, CEPI
  • Representative of W.H.O. (TBC)

The session will now commence at 15:30

  • Dr Tamsyn Barton, Lead Commissioner, ICAI
  • Amanda Glassman, Executive Vice-President and Senior Fellow, Centre for Global Development
  • Dr Charlotte Watts, Chief Scientific Adviser, DFID (also UK CEPI rep)
  • Daniel Graymore, Board Member for UK/Qatar, Gavi and Head of Global Funds, DFID

Purpose of the Session

This session is focused on the UK allocations of funding for research, development and accelerated production of vaccines, treatments and tests in the battle against coronavirus and COVID-19 and continuing efforts to tackle other long-standing diseases and health challenges.

Further information

Image: Pixabay